| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 11/02/2004 | US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 11/02/2004 | US6812237 (arylaminoaceamido)acetonitrile derivatives |
| 11/02/2004 | US6812229 Carbamate derivative and agricultural/horticultural fungicide |
| 11/02/2004 | US6812227 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 11/02/2004 | CA2317736C Bisulfate salt of hiv protease inhibitor |
| 11/02/2004 | CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors |
| 11/02/2004 | CA2129040C Styryl derivatives and processes for their preparation |
| 10/28/2004 | WO2004092157A1 STABLE AMMONIUM SALTS OF α-LIPONIC ACID, THE PRODUCTION THEREOF AND THE USE OF THE SAME |
| 10/28/2004 | WO2004092146A2 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 10/28/2004 | WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators |
| 10/28/2004 | WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 10/28/2004 | WO2004092130A2 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
| 10/28/2004 | WO2004092125A2 Using alkylmetal reagents for directed metalation of azaaromatics |
| 10/28/2004 | WO2004092117A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars |
| 10/28/2004 | WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | WO2004092115A2 Hydroxamates as therapeutic agents |
| 10/28/2004 | WO2004092100A1 Indene derivatives as pharmaceutical agents |
| 10/28/2004 | WO2004091613A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 10/28/2004 | WO2004091604A1 Compounds that modulate ppar activity and methods of preparation |
| 10/28/2004 | WO2004091518A2 Cxcr4 chemokine receptor binding compounds |
| 10/28/2004 | WO2004071442A3 Novel bicyclic compounds and compositions |
| 10/28/2004 | WO2004041151A3 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 10/28/2004 | WO2004038374A3 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 10/28/2004 | WO2004037789A3 Methylene urea derivatives as raf-kinase inhibitors |
| 10/28/2004 | WO2004031427A3 Method for producing a moulded body from sintered steel |
| 10/28/2004 | WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 10/28/2004 | US20040215030 Precursors for metal containing films |
| 10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
| 10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
| 10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 10/28/2004 | US20040214887 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 10/28/2004 | US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 10/28/2004 | US20040214868 Treatment or prevention of type 2 diabetes; chemical synthesis; 2-[ benzoyl]aminopyridine-5-carboxylate derivatives |
| 10/28/2004 | US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS |
| 10/28/2004 | US20040214835 Compounds capable of activating cholinergic receptors |
| 10/28/2004 | US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 10/28/2004 | US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug |
| 10/28/2004 | US20040214198 Allele-targeted RNA interference |
| 10/28/2004 | US20040212773 Redox systems; optical switches |
| 10/28/2004 | US20040211011 Primary intermediates for oxidative coloration of hair |
| 10/28/2004 | CA2527170A1 Therapeutic compounds |
| 10/28/2004 | CA2522470A1 Stable ammonium salts of .alpha.-liponic acid, the production thereof and the use of the same |
| 10/28/2004 | CA2522118A1 Compounds that modulate ppar activity and methods of preparation |
| 10/28/2004 | CA2522080A1 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | CA2521915A1 Alpha substituted carboxylic acid as ppar modulators |
| 10/28/2004 | CA2521883A1 Indene derivatives as pharmaceutical agents |
| 10/28/2004 | CA2521383A1 Using alkylmetal reagents for directed metalation of azaaromatics |
| 10/28/2004 | CA2521175A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars |
| 10/28/2004 | CA2521135A1 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
| 10/28/2004 | CA2520259A1 Cxcr4 chemokine receptor binding compounds |
| 10/27/2004 | EP1471568A1 Precursors for metal containing films |
| 10/27/2004 | EP1471056A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
| 10/27/2004 | EP1470139A2 NOVEL, WATER−SOLUBLE PORPHYRIN PLATINUM COMPOUNDS WITH HIGH TUMOR SELECTIVITY AND THEIR USE FOR THE TREATMENT OF BENIGN AND MALIGNANT TUMOR DISEASES |
| 10/27/2004 | EP1470109A1 Metabolites of (3- [(4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl -phenoxy)-acetic acid |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541206A Substituted dihydro 3-hylo-1H-pyrazoloe-5-carboxylates their prepn. and use |
| 10/27/2004 | CN1541201A Aliphatic amino-substituted demethoxylated hyporcrellins and their synthesis |
| 10/27/2004 | CN1541096A Compounds which mimic chemical and biological properties of discodermolide |
| 10/27/2004 | CN1541086A Dyeing compson. for kerationous fibres comprising particular dicationic diazo dye |
| 10/27/2004 | CN1541063A Method for controlling particular insects by applying anthranilamide compounds |
| 10/27/2004 | CN1539822A Method for preparing 2-aminopyridine and alkyl derivative |
| 10/27/2004 | CN1539821A Molecule material of teera aryl aether pentacites |
| 10/27/2004 | CN1539816A IL-8 receptor antagonist |
| 10/27/2004 | CN1172916C Oxime 0-ether compounds and fungicides for agricultural and horticultural use |
| 10/27/2004 | CN1172915C Method for preparing pyridine alkalis |
| 10/26/2004 | US6809207 Amino acid derivatives |
| 10/26/2004 | US6809109 E.g., 5-bromo-2-(4-chloroanilino)-4-(2,4,6-trimethylphenoxy) pyridine-n-oxide; administering along with an hiv reverse transcriptase inhibitors (polymerase), hiv protease inhibitors, fusion inhibitors or ccr-5; kits |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6808939 Ligand for use as tool in diagnostic analysis |
| 10/26/2004 | US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders |
| 10/26/2004 | US6808827 Organic compound layer(s) include a compound having a transition metal atom-phosphorus atom bond; blue luminescence |
| 10/21/2004 | WO2004090147A1 Method of purifying aqueous amide compound solution and process for producing amide compound |
| 10/21/2004 | WO2004089927A1 Novel methods for the treatment of inflammatory diseases |
| 10/21/2004 | WO2004089922A2 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 10/21/2004 | WO2004089906A2 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides |
| 10/21/2004 | WO2004089905A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 10/21/2004 | WO2004089904A2 Preparation of torasemide |
| 10/21/2004 | WO2004089886A1 Pleuromutilin derivatives, process for their preparation and uses thereof |
| 10/21/2004 | WO2004089885A1 Novel compounds |
| 10/21/2004 | WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 10/21/2004 | WO2004089293A2 Hydroxamic acid compounds and methods of use thereof |
| 10/21/2004 | WO2004089286A2 Novel compounds and compositions as protein kinase inhibitors |
| 10/21/2004 | WO2004067482A3 Substituted anilide ligands for the thyroid receptor |
| 10/21/2004 | WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 10/21/2004 | US20040210060 Process for the separation of enantiomers and enantiopure reagent |
| 10/21/2004 | US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents |
| 10/21/2004 | US20040209936 Compounds that modulate PPAR activity and methods of preparation |
| 10/21/2004 | US20040209927 administering a aminostilbazole, e.g., E)-4-[2-{2-[N-acetyl-N-(4-methoxybenzenesulfonyl)amino]phenyl}ethenyl]pyridine 1-oxide as a Vpr function regulator, useful in the treatment of HIV or AIDS, |
| 10/21/2004 | US20040209926 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma |
| 10/21/2004 | US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 10/21/2004 | US20040209922 Pyridine matrix metalloproteinase inhibitors |